(Date:11/24/2009)...Ambassador to also Visit Detroit , ...avid Appia, French Ambassador for International In...ance Agency, , , , ,What: Ambassador Appia is ava...siness initiatives adopted by France to further de... for innovation and development., , ,When: Availab...
(Date:11/24/2009)...Newswire-FirstCall/--Sigma-AldrichCorporation(Nasd...onTuesday,December1stat1:45PMGMTinLondon,7:45AMUS/...tovertheInternetavailableat http://inve s tor.s...t"icontoaccessthisfile. ,, AboutSigma-Aldrich...logycompany.Itschemicalandbiochemicalproductsandki...
(Date:11/24/2009)...Newswire-Asia/--ShanghaiBiolaxyannouncedthe,Chines...the,investigationalnewdrugapplication(IND)foritsor...lationtotreatdiabetes.ThisIND,approvalallowsBiolax...betesisadisordercharacteristicofhighbloodglucosean...sultinseveremicro-and,macro-vasculardiseases,losso...
(Date:11/24/2009)...PRNewswire-FirstCall/--Shireplc(LSE:SHP,NASDAQ: S...today,announcedthatithassubmittedaMAAtotheEuropean...nzymereplacementtherapyindevelopment,forthetreatme...plicationforvelaglucerasealfathathasbeensubmitted,.... , Basedonaglobalsupplyshortageofthecurrentl...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3(Date:11/25/2009)...v.25/PRNewswire/--SwissrayInternational,Inc.aleadi...tems,announcedtodaythatitsoperationshavebeenacquir...rowingSwissray,smedicalimagingbrand.Theacquisition...ontractsandinventory.After25yearsofsuccessandgrowt...gicaladvancementswithstableandsteadygrowth. ,, ...
(Date:11/25/2009)...5/PRNewswire/--CempraPharmaceuticalsInc.todayannou...utiveofficer,willpresentatthePiperJaffray21stAnnua...atTheNewYorkPalaceHotelinNewYorkCity.Dr.Fernandesw...oticclinicalprogramsforthetreatmentofdrug-resistan...euticals ,, Foundedin2006,CempraPharmaceutical...
(Date:11/25/2009)...ndJOHANNESBURG,November25/PRNewswire/--,iThembaPha...ncedtoday,thattheyhavesignedacollaborativeagreemen...xis,sworldclasscomputationalchemistryandleaddiscov...siontoprovidemedicinaland,syntheticchemistrysuppor...ientnetwork.iThembaPharmaceuticalsandPyxisDiscover...
Breaking Medicine Technology:Swissray International Announces New Ownership 2iThemba Pharmaceuticals (Pty) Ltd and Pyxis Discovery B.V. Announce Collaborative Agreement to Offer a Combined Service Offering 2JNCI news brief 3A High serum insulin levels and risk of prostate cancer 55059 1UCSF researchers identify 2 key pathways in adaptive response 9660 1UCSF researchers identify 2 key pathways in adaptive response 9660 2UCSF researchers identify 2 key pathways in adaptive response 9660 3InfoLogix Files Preliminary Proxy Statement in Connection with Special Meeting of Its Stockholders to Approve Recapitalization Plan 55054 1InfoLogix Files Preliminary Proxy Statement in Connection with Special Meeting of Its Stockholders to Approve Recapitalization Plan 55054 2InfoLogix Files Preliminary Proxy Statement in Connection with Special Meeting of Its Stockholders to Approve Recapitalization Plan 55054 3InfoLogix Files Preliminary Proxy Statement in Connection with Special Meeting of Its Stockholders to Approve Recapitalization Plan 55054 4